Wellgistics Health, Inc. 是一家以药品和医疗服务为核心的控股公司。公司总部位于佛罗里达州坦帕。该公司于2025年2月21日上市。公司专注于专科药品和社区基础模式,为患者提供药品配送上门服务。公司致力于在为药店、医疗机构、制药制造商和保险支付方提供解决方案的同时,改善患者的生活质量。其技术平台DelivMeds作为一个药房枢纽,使临床服务能够与公司的健康药房运营相连接。该平台将提供一个端到端的移动应用程序解决方案,让患者能够数字化他们的处方流程。这一解决方案有助于保障患者的自主权、提高处方药价格透明度,并提供额外的礼宾服务。其产品包括Kyzatrex、司美格鲁肽(Semaglutide)和替尔泊肽(Tirzepatide)。
WGRX stock price ended at $0 on 星期四, after dropping NaN%
On the latest trading day Aug 20, 2026, the stock price of WGRX fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for WGRX decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.